Beijing Sun-Novo Pharmaceutical Research Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Why is Beijing Sun-Novo Pharmaceutical Research Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 16.25% and Operating profit at -8.91% over the last 5 years

Negative results in Sep 25

INTEREST(HY) At CNY 9.06 MM has Grown at 13.2%
NET SALES(Q) At CNY 265.46 MM has Fallen at -24.97%
PRE-TAX PROFIT(Q) At CNY 28.77 MM has Fallen at -56.22%

With ROE of 14.05%, it has a expensive valuation with a 6.69 Price to Book Value

Over the past year, while the stock has generated a return of 33.69%, its profits have fallen by -23.5%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Beijing Sun-Novo Pharmaceutical Research Co., Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

42.81%

0.33

59.11%

China Shanghai Composite

17.07%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

16.25%

EBIT Growth (5y)

-8.91%

EBIT to Interest (avg)

18.77

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.08

Sales to Capital Employed (avg)

0.65

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

10.29%

Pledged Shares

Institutional Holding

ROCE (avg)

25.31%

ROE (avg)

16.49%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

6.69

EV to EBIT

48.36

EV to EBITDA

32.89

EV to Capital Employed

7.43

EV to Sales

6.65

PEG Ratio

Dividend Yield

ROCE (Latest)

15.36%

ROE (Latest)

14.05%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -10.75% (YoY

-18What is not working for the Company

INTEREST(HY)

At CNY 9.06 MM has Grown at 13.2%

NET SALES(Q)

At CNY 265.46 MM has Fallen at -24.97%

PRE-TAX PROFIT(Q)

At CNY 28.77 MM has Fallen at -56.22%

OPERATING CASH FLOW(Y)

Lowest at CNY 76.08 MM

ROCE(HY)

Lowest at 11.6%

NET PROFIT(Q)

At CNY 33.45 MM has Fallen at -43.41%

DEBTORS TURNOVER RATIO(HY)

Lowest at 1.24 times

Here's what is working for Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Raw Material Cost

Fallen by -10.75% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Net Sales

At CNY 265.46 MM has Fallen at -24.97%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit

At CNY 28.77 MM has Fallen at -56.22%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Interest

At CNY 9.06 MM has Grown at 13.2%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Profit

At CNY 33.45 MM has Fallen at -43.41%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow

Lowest at CNY 76.08 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Debtors Turnover Ratio

Lowest at 1.24 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio